withalongolide A 19-acetate;[(1S,2S,6S,7R,9R,11S,12S,15R,16S)-6-hydroxy-15-[(1S)-1-[(2R)-5-(hydroxymethyl)-4-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-16-methyl-3-oxo-8-oxapentacyclo[9.7.0.02,7.07,9.012,16]octadec-4-en-2-yl]methyl acetate
withalongolide A 、 乙酸酐 在
吡啶 作用下,
反应 3.0h,
以25%的产率得到(4S,20S,22R)-27-acetyloxy-4β,19-dihydroxy-5β,6β-epoxy-1-oxowitha-2,24-dienolide
参考文献:
名称:
Synthesis and Cytotoxicity of Semisynthetic Withalongolide A Analogues
摘要:
The natural product withaferin A exhibits potent antitumor activity and other diverse pharmacological activities. The recently discovered withalongolide A, a C-19 hydroxylated congener of withaferin A, was recently reported to possess cytotoxic activity against head and neck squamous cell carcinomas. Semisynthetic acetylated analogues of withalongolide A were shown to be considerably more cytotoxic than the parent compound. To further explore the structure activity relationships, 20 new semisynthetic analogues of withalongolide A were synthesized and evaluated for cytotoxic activity against four different cancer cell lines. A number of derivatives were found to be more potent than the parent compound and withaferin A.
Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
申请人:Timmermann Barbara N.
公开号:US20120196815A1
公开(公告)日:2012-08-02
The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.